The Biomedical Advanced Research and Development Authority (BARDA) this week announced a new solicitation for proposals that advance medical countermeasures such as vaccines, therapeutics and diagnostics for CBRN threats.
Awards under this Broad Agency Announcement (BAA) will serve to advance the knowledge and scientific understanding of candidates‘ countermeasures for CBRN threats toward eventual FDA approval and their inclusion in the Strategic National Stockpile (SNS).
Research areas of interest include:
- Antitoxins and Therapeutics
- Antimicrobial Drugs
- Radiological/Nuclear Threat Medical Countermeasures
- Chemical Threat Medical Countermeasures
- Clinical Diagnostics Tools
The formal BAA is expected to be officially released on July 31, 2013. Further details are available under Solicitation Number: BAA-13-100-SOL-00013.